Avantax Advisory Services’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-7,359
Closed -$220K – 1515
2023
Q1
$220K Buy
7,359
+25
+0.3% +$824 ﹤0.01% 1313
2022
Q4
$225K Buy
+7,334
New +$220K ﹤0.01% 1258
2022
Q3
– Sell
-7,697
Closed -$246K – 1336
2022
Q2
$246K Buy
+7,697
New +$283K ﹤0.01% 1105
2022
Q1
– Sell
-73,284
Closed -$2.46M – 1289
2021
Q4
$2.46M Buy
73,284
+14,618
+25% +$455K 0.04% 329
2021
Q3
$1.71M Buy
58,666
+21,881
+59% +$708K 0.03% 373
2021
Q2
$1.28M Buy
+36,785
New +$1.22M 0.02% 422

Other funds holding CC

Avantax Advisory Services's CC Position: Q2 2023 in Review

Avantax Advisory Services sold out of Chemours (CC) in Q2 2023, closing a stake of 7,359 shares — an estimated $220K sold.

Avantax Advisory Services first reported a position in CC in Q2 2021 and held it in 6 quarters. The position peaked at $2.46M in Q4 2021. 475 funds tracked by Wall St. Rank hold CC as of Q2 2023.

  • Avantax Advisory Services reported no remaining Chemours position as of Q2 2023 after selling out during the quarter.
  • Avantax Advisory Services sold 7,359 Chemours shares in Q2 2023, an estimated $220K.
  • Avantax Advisory Services first reported a position in Chemours in Q2 2021 and held it in 6 quarters.
  • Avantax Advisory Services's Chemours position peaked at $2.46M in Q4 2021.
  • 475 funds tracked by Wall St. Rank held Chemours as of Q2 2023.

Based on Avantax Advisory Services's 13F filing for Q2 2023, filed 11 Aug 2023.